RAMSAY GENERALE DE SANTE SA(EPA:GDS) stock Fundamental Analysis

Fundamental Rating

GDS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 25 industry peers in the Health Care Providers & Services industry. GDS has a bad profitability rating. Also its financial health evaluation is rather negative. GDS does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year GDS has reported negative net income.

GDS had a positive operating cash flow in the past year.

Of the past 5 years GDS 4 years were profitable.

In the past 5 years GDS always reported a positive cash flow from operatings.

1.2 Ratios

GDS has a Return On Assets of -0.78%. This is in the lower half of the industry: GDS underperforms 75.00% of its industry peers.

With a Return On Equity value of -4.51%, GDS is not doing good in the industry: 79.17% of the companies in the same industry are doing better.

The Return On Invested Capital of GDS (1.73%) is worse than 79.17% of its industry peers.

GDS had an Average Return On Invested Capital over the past 3 years of 1.33%. This is below the industry average of 5.68%.

The 3 year average ROIC (1.33%) for GDS is below the current ROIC(1.73%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	-0.78%
ROE	-4.51%
ROIC	1.73%

ROA(3y)0.56%

ROA(5y)0.57%

ROE(3y)3.07%

ROE(5y)3.32%

ROIC(3y)1.33%

ROIC(5y)1.08%

1.3 Margins

The Operating Margin of GDS (2.48%) is worse than 70.83% of its industry peers.

In the last couple of years the Operating Margin of GDS has declined.

The Gross Margin of GDS (78.75%) is better than 75.00% of its industry peers.

In the last couple of years the Gross Margin of GDS has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	2.48%
PM (TTM)	N/A
GM	78.75%

OM growth 3Y24.12%

OM growth 5Y-11.7%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.38%

GM growth 5Y-0.57%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GDS is destroying value.

Compared to 1 year ago, GDS has about the same amount of shares outstanding.

Compared to 5 years ago, GDS has about the same amount of shares outstanding.

Compared to 1 year ago, GDS has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.97, we must say that GDS is in the distress zone and has some risk of bankruptcy.

GDS has a worse Altman-Z score (0.97) than 62.50% of its industry peers.

GDS has a debt to FCF ratio of 9.70. This is a negative value and a sign of low solvency as GDS would need 9.70 years to pay back of all of its debts.

With a Debt to FCF ratio value of 9.70, GDS is not doing good in the industry: 62.50% of the companies in the same industry are doing better.

GDS has a Debt/Equity ratio of 3.10. This is a high value indicating a heavy dependency on external financing.

Looking at the Debt to Equity ratio, with a value of 3.10, GDS is doing worse than 75.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	3.1
Debt/FCF	9.7
Altman-Z	0.97

ROIC/WACC0.39

WACC4.45%

2.3 Liquidity

GDS has a Current Ratio of 0.87. This is a bad value and indicates that GDS is not financially healthy enough and could expect problems in meeting its short term obligations.

GDS has a Current ratio (0.87) which is in line with its industry peers.

A Quick Ratio of 0.80 indicates that GDS may have some problems paying its short term obligations.

GDS has a better Quick ratio (0.80) than 66.67% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.87
Quick Ratio	0.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for GDS have decreased strongly by -209.11% in the last year.

The Revenue has been growing slightly by 6.49% in the past year.

The Revenue has been growing by 8.04% on average over the past years. This is quite good.

EPS 1Y (TTM)-209.11%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-752.19%

Revenue 1Y (TTM)6.49%

Revenue growth 3Y7.57%

Revenue growth 5Y8.04%

Sales Q2Q%5.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GDS. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as GDS.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of GDS indicates a somewhat cheap valuation: GDS is cheaper than 79.17% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	2.81
EV/EBITDA	8.76

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for GDS!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

RAMSAY GENERALE DE SANTE SA

EPA:GDS (2/4/2025, 7:00:00 PM)

10.65

-0.05 (-0.47%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)08-29 2024-08-29

Earnings (Next)N/A N/A

Inst Owners39.92%

Inst Owner ChangeN/A

Ins Owners6.59%

Ins Owner ChangeN/A

Market Cap1.18B

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.23
P/FCF	2.81
P/OCF	2
P/B	0.98
P/tB	N/A
EV/EBITDA	8.76

EPS(TTM)-0.49

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)3.79

FCFY35.58%

OCF(TTM)5.32

OCFY49.91%

SpS45.35

BVpS10.82

TBVpS-9.93

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.78%
ROE	-4.51%
ROCE	2.38%
ROIC	1.73%
ROICexc	1.87%
ROICexgc	3.55%
OM	2.48%
PM (TTM)	N/A
GM	78.75%
FCFM	8.36%

ROA(3y)0.56%

ROA(5y)0.57%

ROE(3y)3.07%

ROE(5y)3.32%

ROIC(3y)1.33%

ROIC(5y)1.08%

ROICexc(3y)1.41%

ROICexc(5y)1.17%

ROICexgc(3y)2.61%

ROICexgc(5y)2.14%

ROCE(3y)1.82%

ROCE(5y)1.48%

ROICexcg growth 3Y32.93%

ROICexcg growth 5Y-19.53%

ROICexc growth 3Y30.51%

ROICexc growth 5Y-13.14%

OM growth 3Y24.12%

OM growth 5Y-11.7%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.38%

GM growth 5Y-0.57%

F-Score4

Asset Turnover0.73

Health

		Industry Rank	Sector Rank
Debt/Equity	3.1
Debt/FCF	9.7
Debt/EBITDA	6.73
Cap/Depr	39.49%
Cap/Sales	3.37%
Interest Coverage	0.62
Cash Conversion	106.56%
Profit Quality	N/A
Current Ratio	0.87
Quick Ratio	0.8
Altman-Z	0.97

F-Score4

WACC4.45%

ROIC/WACC0.39

Cap/Depr(3y)44.5%

Cap/Depr(5y)45.51%

Cap/Sales(3y)3.84%

Cap/Sales(5y)4.08%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-209.11%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-752.19%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)6.49%

Revenue growth 3Y7.57%

Revenue growth 5Y8.04%

Sales Q2Q%5.79%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y29.03%

EBIT growth 3Y33.51%

EBIT growth 5Y-4.6%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-1.97%

FCF growth 3Y-4.21%

FCF growth 5Y63.68%

OCF growth 1Y-2.02%

OCF growth 3Y-3.47%

OCF growth 5Y22.4%

RAMSAY GENERALE DE SANTE SA (GDS.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens